Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Monatide (IMS 3015) × Clear all

NCT01265433 2024-10-09

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

Phase 2 Completed

41 enrolled 12 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant